Catalyst Wire Dossier Catalyst Wire Dossier

Anti-E1E2 Antibodies

D32.10 Epitope-binding Antibodies
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-E1E2 Antibodies, covering 2016-08-26 to 2016-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy

See pricing